Ergoteles LLC bought a new stake in shares of Viemed Healthcare, Inc. (NASDAQ:VMD) in the 1st quarter, HoldingsChannel reports. The firm bought 11,400 shares of the company’s stock, valued at approximately $115,000.
A number of other hedge funds have also added to or reduced their stakes in VMD. Denali Advisors LLC acquired a new stake in Viemed Healthcare during the first quarter valued at approximately $32,000. Lazard Asset Management LLC acquired a new stake in Viemed Healthcare during the fourth quarter valued at approximately $46,000. Public Employees Retirement System of Ohio acquired a new stake in Viemed Healthcare during the fourth quarter valued at approximately $92,000. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in shares of Viemed Healthcare by 135.0% in the 1st quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 9,259 shares of the company’s stock valued at $94,000 after acquiring an additional 5,319 shares in the last quarter. Finally, Trexquant Investment LP purchased a new stake in shares of Viemed Healthcare in the 4th quarter valued at approximately $115,000. 51.10% of the stock is owned by institutional investors and hedge funds.
Several equities research analysts recently commented on the stock. Zacks Investment Research downgraded shares of Viemed Healthcare from a “hold” rating to a “sell” rating in a research report on Friday, May 7th. Royal Bank of Canada assumed coverage on shares of Viemed Healthcare in a research report on Friday, March 5th. They issued an “outperform” rating and a $13.00 price target for the company. Finally, TheStreet upgraded shares of Viemed Healthcare from a “c” rating to a “b+” rating in a research report on Monday, March 8th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and two have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average price target of $12.33.
Viemed Healthcare (NASDAQ:VMD) last released its earnings results on Monday, May 3rd. The company reported $0.04 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.03 by $0.01. Viemed Healthcare had a net margin of 21.32% and a return on equity of 37.21%. The company had revenue of $28.42 million during the quarter, compared to the consensus estimate of $29.00 million. As a group, analysts expect that Viemed Healthcare, Inc. will post 0.25 EPS for the current fiscal year.
Viemed Healthcare Profile
Viemed Healthcare, Inc, through its subsidiaries, provides in-home durable medical equipment and post-acute respiratory healthcare services to patients in the United States. The company offers respiratory services and related equipment, including non-invasive ventilators; bi-level, continuous, and automatic continuous positive airway pressure (PAP) machines; and oxygen therapy, as well as services of respiratory therapists; and respiratory disease management, neuromuscular care, and oxygen therapy services.
Featured Article: Investing in Dividend Stocks
Want to see what other hedge funds are holding VMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Viemed Healthcare, Inc. (NASDAQ:VMD).
Receive News & Ratings for Viemed Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viemed Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.